DNA RNA and Cells

15 Jun 2010 TxCell Successfully Completes Preclinical Development of TX-RAD in Inflammatory Arthritis
09 Jun 2010 Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases
08 Jun 2010 Efficacy of MGN1703 DNA cancer medicine far exceeds
07 Jun 2010 XCell-Center GmbH Gets Approval by French Health Authorities to Conduct Clinical Trial with Stem Cells for Chronic Spinal Cord Injury
07 Jun 2010 Alnylam Presents Preliminary Phase I Data at American Society of Clinical Oncology (ASCO) Meeting for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers
07 Jun 2010 OncoGenex Pharmaceuticals Announces Final Results from Phase 1 Trial Evaluating OGX-427 as a Treatment for Solid Tumors
06 Jun 2010 Pooled Results of Early Endpoints from Phase 3 Trials of Genasense® in Advanced Melanoma Presented at ASCO
05 Jun 2010 Phase 3 Study Showed MACUGEN Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema
04 Jun 2010 Idera Pharmaceuticals Announces Publication of Preclinical Data on Cancer Immunotherapy with its Dual Agonist of Toll-like Receptors 7 and 8
04 Jun 2010 Biomet Announces Enrollment of First Subject into Its Investigational Device Exemption Clinical Trial for Critical Limb Ischemia Utilizing Autologous Concentrated Bone Marrow Aspirate
03 Jun 2010 AVI-4658 Demonstrates First Ever Reported Generation of Greater Than 50% Dystrophin-Positive Muscle Fibers in a Patient Following Systemic Administration in Duchenne Muscular Dystrophy; All Patients
01 Jun 2010 Tekmira Reports Complete Protection from Deadly Ebola Virus in Nonhuman Primates with SNALP-RNAi
30 May 2010 Targeted Genetics' Partner Celladon Corporation Reports Positive Phase 2 Clinical Trial Data at Heart Failure Association Annual Meeting
26 May 2010 CoDa Therapeutics Achieves Positive Phase 2 Efficacy of NEXAGON in Chronic Venous Leg Ulcers
24 May 2010 Neuralstem Updates Clinical Trial Progress
22 May 2010 VIRxSYS Presents Results from Multiple Studies at the 13th ASGCT Annual Meeting
20 May 2010 Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
20 May 2010 Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
20 May 2010 New Data from Adrenoleukodystrophy (ALD) Pilot Study Presented at American Society of Gene and Cell Therapy Show Three-Year Disease Stabilization of Patients
19 May 2010 UNITED STATES FDA CLEARS PHASE 2 TRIAL FOR CERVICAL SPINAL FUSION
19 May 2010 Oncolytic viruses mediating anti-tumor immunity in human cancer patients published by Oncos Therapeutics and University of Helsinki Oncos Therapeutics
17 May 2010 First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
14 May 2010 Geron Annonces Positive Study Data on GRNCM1
14 May 2010 Neotropix Announces Enrollment of Patients in NCI-Sponsored Phase II Clinical Trial for Small Cell Lung Cancer
13 May 2010 Fibrocell Science, Inc. Initiates Histology Study of azficel-T

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top